Cargando…

Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients

CONTEXT: Intensive care unit (ICU) patients suffer from various comorbidities and usually receive complex pharmacotherapy which increases the risk of drug-drug interactions (DDIs). AIM: To identify and assess potential DDIs (pDDIs) in ICU patients. SETTINGS AND DESIGN: A prospective observational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagh, Bhavika Ravindra, Godbole, Deepa Dhananjay, Deshmukh, Shubham Shivaji, Iyer, Shivakumar, Deshpande, Prasanna R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521822/
https://www.ncbi.nlm.nih.gov/pubmed/31130787
http://dx.doi.org/10.5005/jp-journals-10071-23147
_version_ 1783419039998017536
author Wagh, Bhavika Ravindra
Godbole, Deepa Dhananjay
Deshmukh, Shubham Shivaji
Iyer, Shivakumar
Deshpande, Prasanna R
author_facet Wagh, Bhavika Ravindra
Godbole, Deepa Dhananjay
Deshmukh, Shubham Shivaji
Iyer, Shivakumar
Deshpande, Prasanna R
author_sort Wagh, Bhavika Ravindra
collection PubMed
description CONTEXT: Intensive care unit (ICU) patients suffer from various comorbidities and usually receive complex pharmacotherapy which increases the risk of drug-drug interactions (DDIs). AIM: To identify and assess potential DDIs (pDDIs) in ICU patients. SETTINGS AND DESIGN: A prospective observational study conducted in ICU of a tertiary care hospital for a period of 6 months. MATERIALS AND METHODS: Patient information was noted in the data collection form and pDDIs were assessed using Micromedex®database. STATISTICAL ANALYSIS USED: Chi-square test was used to find correlation of pDDIs with patient parameters. p value was calculated keeping the significance level 0.05. RESULTS: Total 400 subjects were included; having an average age of 55.99 ± 15.62 years with a higher percentage of males (61.75%). About 305 (76.25%) patients were found with pDDIs, showing an average of 2.93 pDDIs/patient. The findings of this study were as follows: Total interactions = 1171, contraindicated = 6 (1%), major = 715 (61%), moderate = 428 (36%), and minor = 22 (2%) pDDIs. Further, majority of pDDIs had onset of action “not specified” documentation “fair” and probable mechanism “pharmacodynamic” in nature. Significant association of occurrence of pDDIs was found with number of drugs prescribed to patients in ICU. CONCLUSION: This study demonstrated a high prevalence of pDDI in ICU due to the complexity of pharmacotherapy which showed major pDDIs as the most evident (61%) while contraindicated were 1%. Further studies are needed to better explore this area which may help in realizing the goal of good clinical practice and may offer a methodology to further increase drug safety. KEY MESSAGES: “Monitoring and assessment of DDIs is needed for better patient care”. HOW TO CITE THIS ARTICLE: Wagh BR, Godbole DD, et al. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients. Indian J Crit Care Med 2019;23(4):170-174.
format Online
Article
Text
id pubmed-6521822
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-65218222019-05-24 Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients Wagh, Bhavika Ravindra Godbole, Deepa Dhananjay Deshmukh, Shubham Shivaji Iyer, Shivakumar Deshpande, Prasanna R Indian J Crit Care Med Original Article CONTEXT: Intensive care unit (ICU) patients suffer from various comorbidities and usually receive complex pharmacotherapy which increases the risk of drug-drug interactions (DDIs). AIM: To identify and assess potential DDIs (pDDIs) in ICU patients. SETTINGS AND DESIGN: A prospective observational study conducted in ICU of a tertiary care hospital for a period of 6 months. MATERIALS AND METHODS: Patient information was noted in the data collection form and pDDIs were assessed using Micromedex®database. STATISTICAL ANALYSIS USED: Chi-square test was used to find correlation of pDDIs with patient parameters. p value was calculated keeping the significance level 0.05. RESULTS: Total 400 subjects were included; having an average age of 55.99 ± 15.62 years with a higher percentage of males (61.75%). About 305 (76.25%) patients were found with pDDIs, showing an average of 2.93 pDDIs/patient. The findings of this study were as follows: Total interactions = 1171, contraindicated = 6 (1%), major = 715 (61%), moderate = 428 (36%), and minor = 22 (2%) pDDIs. Further, majority of pDDIs had onset of action “not specified” documentation “fair” and probable mechanism “pharmacodynamic” in nature. Significant association of occurrence of pDDIs was found with number of drugs prescribed to patients in ICU. CONCLUSION: This study demonstrated a high prevalence of pDDI in ICU due to the complexity of pharmacotherapy which showed major pDDIs as the most evident (61%) while contraindicated were 1%. Further studies are needed to better explore this area which may help in realizing the goal of good clinical practice and may offer a methodology to further increase drug safety. KEY MESSAGES: “Monitoring and assessment of DDIs is needed for better patient care”. HOW TO CITE THIS ARTICLE: Wagh BR, Godbole DD, et al. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients. Indian J Crit Care Med 2019;23(4):170-174. Jaypee Brothers Medical Publishers 2019-04 /pmc/articles/PMC6521822/ /pubmed/31130787 http://dx.doi.org/10.5005/jp-journals-10071-23147 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Wagh, Bhavika Ravindra
Godbole, Deepa Dhananjay
Deshmukh, Shubham Shivaji
Iyer, Shivakumar
Deshpande, Prasanna R
Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title_full Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title_fullStr Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title_full_unstemmed Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title_short Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients
title_sort identification and assessment of potential drug-drug interactions in intensive care unit patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521822/
https://www.ncbi.nlm.nih.gov/pubmed/31130787
http://dx.doi.org/10.5005/jp-journals-10071-23147
work_keys_str_mv AT waghbhavikaravindra identificationandassessmentofpotentialdrugdruginteractionsinintensivecareunitpatients
AT godboledeepadhananjay identificationandassessmentofpotentialdrugdruginteractionsinintensivecareunitpatients
AT deshmukhshubhamshivaji identificationandassessmentofpotentialdrugdruginteractionsinintensivecareunitpatients
AT iyershivakumar identificationandassessmentofpotentialdrugdruginteractionsinintensivecareunitpatients
AT deshpandeprasannar identificationandassessmentofpotentialdrugdruginteractionsinintensivecareunitpatients